Advanced imaging systems let Lincolnshire treat more complex cases closer to home
United Lincolnshire Teaching Hospitals (ULTH) says the introduction of specialist radiology equipment at its Lincoln and Boston sites is enabling clinicians to perform a wider range of complex procedures locally, reducing referrals to tertiary centres and shortening waiting times for patients.
The trust has installed two Canon Alphenix interventional platforms: the Alphenix Core plus at Pilgrim Hospital, Boston, which was commissioned last summer, and the Alphenix Sky plus at Lincoln County Hospital, brought into service in early 2022. According to the trust’s radiology operations manager, the systems have increased the scope of interventions the hospitals can support.
“We can offer a bigger variety of procedures. The clinical businesses that we support do not send patients to wait at tertiary centres like Leicester or Nottingham when we can provide them here in Lincolnshire.”
The Trust highlights several clinical and operational benefits from the new kit. Most notably, teams say the systems are helping to:
- perform more embolisations and vascular procedures that contribute to meeting nationally set targets;
- intervene earlier in complex cases, potentially avoiding more invasive operations later on;
- reduce the need for patients to travel long distances for tertiary centre appointments, which is particularly important in areas with limited public transport links.
Those outcomes matter because earlier, less invasive interventions can shorten recovery times and ease pressure on surgical waiting lists. ULTH told the Local Democracy Reporting Service that the high-definition detector technology on the Alphenix platforms enhances visual detail in the target area, allowing clinicians to work faster and with greater precision.
Practical effects on patient pathways and system capacity
By expanding the range of procedures available locally, the trust says it can keep more patients within Lincolnshire rather than transferring them to regional centres such as Leicester or Nottingham. That change affects both patients and workforce planning: fewer outbound referrals should reduce travel burdens for patients and free up appointment slots at tertiary units.
Mark Dorn, radiology operations manager at ULTH, explained that being able to deliver interventions sooner can stop conditions escalating into problems that require major surgery. He pointed to embolisation procedures and the meeting of vascular targets as examples where the new technology has made a tangible difference.
| Hospital | System | Commissioned |
|---|---|---|
| Pilgrim Hospital, Boston | Alphenix Core plus | Last summer |
| Lincoln County Hospital | Alphenix Sky plus | Early 2022 |
ULTH says the technology is chiefly used for complex conditions such as renal and high‑risk cardiovascular cases, along with other specialist needs that previously might have required referral to a tertiary centre with more advanced interventional radiology capability.
Context and limitations
Installing advanced interventional radiology platforms is not a panacea. While the enhanced imaging and detector technology can speed up procedures and broaden local case mix, the full benefit depends on staffing, operating theatre availability and post‑procedure care. The trust’s comments focus on clinical capability and patient convenience; they do not detail the programme’s capital or running costs, staff training timelines, or exact effects on waiting‑time statistics — information that would be needed to quantify system‑level gains.
Nevertheless, the reported changes align with wider NHS priorities: increasing the capacity to treat patients closer to home, reducing unnecessary travel, and using technology to avoid more invasive surgery where possible. For communities in Lincolnshire, where transport links can be patchy, keeping care local can materially reduce barriers to timely treatment.
As trusts across the country invest in diagnostic and interventional kit, the focus will shift to how well such investments are integrated into care pathways and whether they translate into sustained reductions in referrals and operations at distant tertiary centres. For ULTH, the early signs suggest the Alphenix platforms are helping clinicians to deliver more complex care without moving patients out of the county — but independently verifiable outcome data would be required to confirm the scale of the improvement.
For patients, clinicians and commissioners alike, the test now is whether enhanced imaging capability produces measurable improvements in waiting times, treatment complexity handled locally, and overall NHS efficiency.
